Back

Experience with tecarfarin, a novel vitamin K antagonist: use with reversing agents and in mechanical heart valve recipients

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 4 - Thrombosis and coagulation Thrombosis and coagulation ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Mark Midei

Armetheon, Monkton (United States of America)

9 More presentations in this session

Presentation thumbnail
Elevated lipoprotein a levels in patients with prosthetic valve thrombosis
Professor M. Ozkan (Istanbul, TR)
Abstract Slides
Presentation thumbnail
Concentration dependent effects of edoxaban on thrombin generation kinetics and physical characteristics of clot By CAT and TEG6 assay
Doctor U. Tantry
Abstract Slides
Presentation thumbnail
Demographic and clinical characteristics associated with initiation of individual oral anticoagulants among patients with newly diagnosed venous thromboembolism
Doctor X. Li (Princeton, US)
Abstract Slides
Presentation thumbnail
Management of deep vein thrombosis in a multidisciplinary team
Doctor A. Albertsen (Viborg, DK)
Abstract Slides
Presentation thumbnail
Cancer, chronic kidney disease and thrombosis.
Professor I. Elalamy (Marrakech, MA)
Abstract Slides

Access the full session

Session thumbnail
Poster session 4 - Thrombosis and coagulation

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources